You can see this clearly in Medicaid programs, too: as of January 2026, only about 13 states covered GLP-1 medications for weight loss
Comfort, Technique, and Debunking Myths Theres plenty of misinformation floating around about administering semaglutide
(2024, September) The article highlights the remarkable progress in GLP-1 receptor therapies, with semaglutide standing out for its powerful effects beyond glucose control (notably in weight loss, cardiovascular protection, and potential benefits for liver and brain health)
We do our best to get to know our clients, understand their situations, and get them the compensation they deserve
Are you early in treatment and still increasing your dose
An estimated 15 million Americans are now taking GLP-1 drugs for weight loss